Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1176-1177
doi: 10.1161/01.CIR.0000029209.89156.88
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meuwissen, M.
Right arrow Articles by Piek, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meuwissen, M.
Right arrow Articles by Piek, J. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
Related Collections
Right arrow Restenosis

(Circulation. 2002;106:1176.)
© 2002 American Heart Association, Inc.


Images in Cardiovascular Medicine

Stent Inflammation

Stent Footprint in Restenotic Tissue Retrieved by Directional Atherectomy

Martijn Meuwissen, MD; Allard C. van der Wal, MD; Robbert J. de Winter, MD; Karel T. Koch, MD; Anton E. Becker, MD; Jan J. Piek, MD

From the Departments of Cardiology (M.M., R.J.d.W., K.T.K., J.J.P.) and Cardiovascular Pathology (A.C.v.d.W., A.E.B.), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Correspondence to Jan J. Piek, MD, Dept of Cardiology, B2-108, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands, PO Box 22700, 1100 DE Amsterdam, The Netherlands. E-mail m.meuwissen@amc.uva.nl


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

A 68-year-old woman was treated for diffuse in-stent restenosis 5 months after implantation of a 13-mm Multilink stent (Guidant) in the proximal segment of the right coronary artery (Figure 1A). Debulking of the in-stent restenotic lesion was performed using directional coronary atherectomy (DCA) followed by adjunctive balloon angioplasty (Figure 1B). Six months after atherectomy, the patient was asymptomatic and routine coronary angiography demonstrated a good long-term result (Figure 1C). Macroscopic examination of the retrieved DCA specimen revealed a partially removed stent strut (arrow, Figure 2A) within transparent blueish homogeneous tissue. The atherectomy specimen was analyzed histologically and contained mainly smooth muscle cells. At regular intervals along the edge, distinct clusters of T lymphocytes and macrophages (not shown) occurred, suggesting inflammatory cell clustering at the site of stent struts (Figures 2B and 2C). These immunohistochemical images illustrate a stent-strut– induced inflammation of an in-stent restenotic lesion retrieved by DCA.


Figure Removed (Available Only in the Full Text)
View larger version (60K):
[in this window]
[in a new window]
 
Figure 1. A, Coronary angiogram of the right coronary artery, showing a severe, proximal in-stent restenotic lesion. B, Coronary angiogram directly after directional coronary atherectomy followed by adjunct balloon angioplasty. C, Coronary angiogram at 6-month follow-up.


Figure Removed (Available Only in the Full Text)
View larger version (70K):
[in this window]
[in a new window]
 
Figure 2. A, Macroscopic view of the retrieved atherectomy specimen. Arrow indicates a partially removed stent strut. B, Anti–{alpha}1-smooth muscle actin (SMA-1) staining shows predominantly smooth muscle cells. C, CD-3 staining shows clustered inflammatory (T) cells at regular intervals along the edge of the atherectomy specimen, representing stent-strut–induced inflammatory processes (asterisks).

The editor of Images in . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
W. J. Gomes and E. Buffolo
Coronary stenting and inflammation: implications for further surgical and medical treatment.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1918 - 1925.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-X. Chen, X. Ma, S. Whitman, and E. R. O'Brien
Novel Antiinflammatory Vascular Benefits of Systemic and Stent-Based Delivery of Ethylisopropylamiloride
Circulation, December 14, 2004; 110(24): 3721 - 3726.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
X. Ma and E. R. O'Brien
Antagonism of the {alpha}4 integrin subunit attenuates the acute inflammatory response to stent implantation yet is insufficient to prevent late intimal formation
J. Leukoc. Biol., June 1, 2004; 75(6): 1016 - 1021.
[Abstract] [Full Text] [PDF]